Wednesday, LifeStance Health Group Inc (NASDAQ:LFST) reported fourth-quarter 2023 revenue of $280.60 million, up 22% Y/Y, beating the consensus of $263 million. Strong revenue growth in the fourth quarter was driven primarily by net clinician growth, increased visit volumes, and total revenue per visit improvements. The clinician base expanded by 18%, reaching 6,645 clinicians, with an addition of 227 clinicians in the fourth quarter and 1,014 for the full year. Fourth quarter visit volumes increased by 20% to 1.8 million, contributing to a full-year visit volume increase of 20% to 6.9 million…